SCHEMBL2371733

SCHEMBL2371733

Oc1ccn(-c2ccccc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.52
MAPT P10636 2/20 0.49
HTT P42858 2/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
GAA P10253 2/20 0.45
ELOVL1 Q9BW60 5/20 0.44
LMNA P02545 1/20 0.42
ESR2 Q92731 1/20 0.42
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2384190 0.78 ALDH1A1 (0.47) MAPTL3MBTL1GAALMNAKDM4E
SCHEMBL6075526 0.78 KMT2A (0.53) MAPTL3MBTL1ELOVL1LMNAKDM4E
SCHEMBL15352886 0.78 KMT2A (0.40) CYP2C9MAPTHTTTSHRKDM4E
SCHEMBL7092735 0.78 ALDH1A1 (0.49) MAPTHTTGAALMNAKDM4E
SCHEMBL28835069 0.78 CYP2A6 (0.53) HTTGAA
SCHEMBL30354367 0.77 ALDH1A1 (0.46) MAPTL3MBTL1GAALMNAKDM4E
SCHEMBL29000076 0.77 ALDH1A1 (0.46) MAPTL3MBTL1GAALMNAKDM4E
SCHEMBL13736329 0.77 MAPT (0.48) CYP2C9MAPTTSHRKDM4ENPC1
SCHEMBL15352613 0.77 MEN1 (0.57) L3MBTL1ALDH1A1
SCHEMBL15352749 0.77 SMN1; SMN2 (0.41) MAPTHTTLMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5681755-A SOLUTION COMPRISING METAL IONS, MOLAR EXCESS OF HISTIDINE OR IMIDAZOLE COMPLEXING AGENT, REDUCING AGENT; QUALITATIVE OR QUANTITATIVE DETERMINATION OF COMPONENTS OF AGGREGATE JANSSEN PHARMACEUTICA N.V. (BE) 1997-10-28 US claimed
US-5674755-A Method for depositing metal particles on a marker JANSSEN PHARMACEUTICA N.V. (BE) 1997-10-07 US claimed
EP-0446993-B1 Light stable physical developer JANSSEN PHARMACEUTICA NV (BE) 1997-06-04 EP claimed
US-5206122-A Aqueous solution of silver ions, desensitizer, reducing agent; immunological detection of antigens JANSSEN PHARMACEUTICA N.V. (BE) 1993-04-27 US claimed
EP-0293947-B1 METHOD FOR DEPOSITING METAL PARTICLES ON A MARKER JANSSEN PHARMACEUTICA N.V. (BE) 1992-11-25 EP claimed
EP-0446993-A1 Light stable physical developer JANSSEN PHARMACEUTICA N.V. (BE) 1991-09-18 EP claimed
EP-0293947-A1 Method for depositing metal particles on a marker JANSSEN PHARMACEUTICA N.V. (BE) 1988-12-07 EP claimed
CN-116003322-B Pyrazole ether compound as well as preparation method and application thereof 南通泰禾化工股份有限公司 2024-05-31 CN disclosed
CN-116003322-A Pyrazole ether compound as well as preparation method and application thereof 南通泰禾化工股份有限公司 2023-04-25 CN disclosed
WO-2023284761-A1 PYRAZOLE ETHER COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 南通泰禾化工股份有限公司 2023-01-19 WO disclosed
WO-2023284761-A1 PYRAZOLE ETHER COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 南通泰禾化工股份有限公司 2023-01-19 WO disclosed
CN-108503587-B Amide compound and application thereof 上海晓明检测技术服务有限公司 2022-07-01 CN disclosed
CN-109096194-B Biguanide derivative, pharmaceutical composition, preparation method and application 湖南师范大学 2022-02-08 CN disclosed
EP-0401913-B1 A solid phase assay for use with a physical developer JANSSEN PHARMACEUTICA NV (BE) 1995-01-25 EP disclosed
US-5206122-A Aqueous solution of silver ions, desensitizer, reducing agent; immunological detection of antigens JANSSEN PHARMACEUTICA N.V. (BE) 1993-04-27 US disclosed
EP-0293947-B1 METHOD FOR DEPOSITING METAL PARTICLES ON A MARKER JANSSEN PHARMACEUTICA N.V. (BE) 1992-11-25 EP disclosed
EP-0446993-A1 Light stable physical developer JANSSEN PHARMACEUTICA N.V. (BE) 1991-09-18 EP disclosed
EP-0401913-A1 A solid phase assay for use with a physical developer JANSSEN PHARMACEUTICA N.V. (BE) 1990-12-12 EP disclosed
EP-0293947-A1 Method for depositing metal particles on a marker JANSSEN PHARMACEUTICA N.V. (BE) 1988-12-07 EP disclosed
US-4531005-A Pyrazol-4-yl phosphites TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-07-23 US disclosed